| Literature DB >> 33725977 |
Ping Li1, Yabing Tang, Yurong Jiang, Dezhong Li.
Abstract
ABSTRACT: Pernicious placenta previa (PEPP) is a severe complication of late pregnancy, which might result in adverse maternal-fetal outcome. To explore the application value of placenta accreta score (PAS) for PEPP and its association with maternal-fetal outcome.In this retrospective cohort study, the clinical data of PEPP patients were analyzed. According to the ultrasonic PAS, patients were grouped into 3 groups: scores ≤5, a scores between 6 and 9, and scores ≥10. The clinical data, intraoperative and postoperative outcomes were collected. Receiver operating characteristic (ROC) curves were used to evaluate the performance of PAS in disease severity evaluation. Multivariate logistic and linear regression analysis were performed to assess associations of PAS with intraoperative and postoperative outcomes.A total of 231 patients were enrolled. There were significant differences in intraoperative, postoperative and neonatal outcomes, such as operation time, bladder repair, ICU admission, postoperative hospitalization days, operation complications, Apgar score of newborns in 1 minute and premature delivery among the 3 groups (all P < .05), while the worst outcomes were found in those with a score ≥ 10 (all P < .05). According to ROC curves, scores <5.5, between 5.5 and 7.5, and >7.5 indicated placenta accreta, placenta increta and placenta percreta, respectively. PAS was independently associated with longer time of operation, surgical complications, intraoperative bleeding volume, and postoperative hospitalization days (all P < .05).Placenta accreta score might help with PEPP subtype diagnosis and predict the maternal-fetal outcome of PEPP patients.Entities:
Mesh:
Year: 2021 PMID: 33725977 PMCID: PMC7982193 DOI: 10.1097/MD.0000000000025023
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.817
Characteristics of patients.
| Characteristics | ≤5 points (n = 101) | 6–9 points (n = 100) | ≥10 points (n = 30) | |
| Age, years | 32.95 ± 3.89 | 33.36 ± 4.13 | 33.73 ± 4.18 | .590 |
| Gestational weeks, weeks | 36.04 ± 1.71 | 35.96 ± 1.27 | 35.34 ± 1.89 | .091 |
| Pregnancy times | 3.87 ± 1.55 | 3.99 ± 1.45 | 4.53 ± 1.59 | .111 |
| Parity, times | 1.10 ± 0.33 | 1.17 ± 0.43 | 1.43 ± 0.57∗,† | .001 |
| Induced abortion, times | 1.75 ± 1.47 | 1.81 ± 1.28 | 2.07 ± 1.36 | .545 |
| Cesarean section, times | 1.05 ± 0.22 | 1.10 ± 0.33 | 1.33 ± 0.55∗,† | <.001 |
| Preoperative Hemoglobin, g | 113.08 ± 11.84 | 112.35 ± 10.95 | 111.57 ± 14.08 | .802 |
| Body mass index, kg/m2 | 26.48 ± 2.91 | 26.50 ± 2.85 | 26.26 ± 2.31 | .915 |
When comparing
with the group with a score ≤5, P < .05, and when comparing.
with the group with a score between 6 and 9, P < .05.
Data displayed as mean (SD).
Comparison of intraoperative outcomes.
| Intraoperative conditions | ≤5 points (n = 101) | 6–9 points (n = 100) | ≥10 points (n = 30) | |
| Intraoperative bleeding volume, ml, median (Q1, Q3) | 400 (300, 500) | 600 (400, 1075)∗ | 2000 (1075, 3550)∗,† | <.001 |
| Autologous blood transfusion, n (%) | 6 (5.9) | 27 (26.7)∗ | 22 (73.3)∗,† | <.001 |
| Hysterectomy, n (%) | 1 (1.0) | 4 (4.0) | 10 (33.3)∗,† | <.001 |
| Emergency operation, n (%) | 10 (9.9) | 6 (6.0) | 5 (16.7) | .190 |
| Time of operation, n (%) | <.001 | |||
| < 3h | 97 (96.0) | 83 (83.0) | 11 (36.7) | |
| > 3h | 4 (4.0) | 17 (17.0) | 19 (63.3)∗,† | |
| Bladder repair, n (%) | 1 (1.0) | 1 (1.0) | 5 (16.7)∗,† | <.001 |
| ICU admission, n (%) | 3 (3.0) | 13 (13.0)∗ | 17 (56.7)∗,† | <.001 |
When comparing:
with the group with a score ≤ 5, P < .05, and when comparing.
with the group with a score between 6 and 9, P < .05.
Comparison of Postoperative and Neonatal Conditions.
| Postoperative and neonatal conditions | ≤5 points (n = 101) | 6–9 points (n = 100) | ≥10 points (n = 30) | |
| Neonatal weight, g, mean (SD) | 2805.94 ± 480.85 | 2702.50 ± 447.52 | 2598.33 ± 630.47 | .088 |
| 1-minute Apgar score of newborns, mean (SD) | 9.99 ± 0.10 | 10.00 ± 0.00 | 9.90 ± 0.40∗,† | .009 |
| Newborn male gender, n (%) | 58 (57.4) | 53 (53.0) | 17 (56.7) | .810 |
| Premature delivery, n (%) | 68 (67.3) | 85 (85.0)∗ | 26 (86.7)∗ | .005 |
| Postoperative hospitalization days, days, median (range) | 4 (4, 5.5) | 6 (4, 7)∗ | 8 (6, 10)∗,† | <.001 |
| Surgical complications, n (%) | 5 (5.0) | 17 (17.0)∗ | 7 (23.3)∗ | .006 |
When comparing:
with the group with a score ≤ 5, P < .05, and when comparing.
with the group with a score between 6 and 9, P < .05.
SD = standard deviation.
Figure 1ROC curves for placenta increta and placenta accrete.
Figure 2ROC curves of placenta increta and placenta percreta.
Figure 3ROC curves for placenta accreta and placenta percreta.